DK194377A - Pyrrolidoner samt deres fremstilling og anvendelse - Google Patents
Pyrrolidoner samt deres fremstilling og anvendelseInfo
- Publication number
- DK194377A DK194377A DK194377A DK194377A DK194377A DK 194377 A DK194377 A DK 194377A DK 194377 A DK194377 A DK 194377A DK 194377 A DK194377 A DK 194377A DK 194377 A DK194377 A DK 194377A
- Authority
- DK
- Denmark
- Prior art keywords
- pyrrolidones
- manufacture
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000004040 pyrrolidinones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762619638 DE2619638A1 (de) | 1976-05-04 | 1976-05-04 | Pyrrolidone und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK194377A true DK194377A (da) | 1977-11-05 |
Family
ID=5977020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK194377A DK194377A (da) | 1976-05-04 | 1977-05-03 | Pyrrolidoner samt deres fremstilling og anvendelse |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS52133975A (da) |
| BE (1) | BE854268A (da) |
| DE (1) | DE2619638A1 (da) |
| DK (1) | DK194377A (da) |
| ES (1) | ES458264A1 (da) |
| FR (1) | FR2372806A1 (da) |
| GB (1) | GB1583163A (da) |
| IT (1) | IT1086223B (da) |
| NL (1) | NL7704739A (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4320136A (en) | 1980-08-11 | 1982-03-16 | E. I. Du Pont De Nemours And Company | 8-Aza-16,16-difluoroprostanoids |
| US4321201A (en) | 1980-09-22 | 1982-03-23 | E. I. Du Pont De Nemours And Company | Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates |
| EP0440789A1 (de) * | 1988-04-22 | 1991-08-14 | 2-i MOSKOVSKY GOSUDARSTVENNY MEDITSINSKY INSTITUT IMENI N.I. PIROGOVA | Carbalkoxymethylether von lactam-1-essigsäure sowie herstellungsverfahren |
| GEP20043203B (en) | 1999-12-22 | 2004-03-25 | Pfizer Prod Inc | EP4 Receptor Selective Agonists in the Treatment of Osteoporosis |
| AU2001290250A1 (en) * | 2000-09-21 | 2002-04-02 | Ono Pharmaceutical Co. Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| OA12533A (en) * | 2000-11-27 | 2006-06-05 | Pfizer Prod Inc | Ep4 receptor selective agonists in the treatment of osteoporosis. |
| CA2451392A1 (en) * | 2001-07-16 | 2003-01-30 | F. Hoffmann-La Roche Ag | Prostaglandin analogues as ep4 receptor agonists |
| CN100371322C (zh) | 2001-07-16 | 2008-02-27 | 霍夫曼-拉罗奇有限公司 | 作为前列腺素类化合物激动剂的2-吡咯烷酮衍生物 |
| EP2255829A3 (en) | 2001-07-23 | 2012-03-28 | Ono Pharmaceutical Co., Ltd. | Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient |
| AU2003211574A1 (en) | 2002-03-05 | 2003-09-16 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| JP4754820B2 (ja) * | 2002-06-10 | 2011-08-24 | メルク セローノ ソシエテ アノニム | プロスタグランジン作動薬としてのγラクタムおよびその使用 |
| CA2511255C (en) | 2003-01-10 | 2009-04-07 | F. Hoffmann-La Roche Ag | 2-piperidone derivatives as prostaglandin agonists |
| US7256211B1 (en) * | 2003-01-21 | 2007-08-14 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivatives and medical use thereof |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| JP4893999B2 (ja) * | 2004-10-22 | 2012-03-07 | 小野薬品工業株式会社 | 吸入用医薬組成物 |
| WO2014015247A1 (en) | 2012-07-19 | 2014-01-23 | Cayman Chemical Company, Inc. | Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions |
| US9676712B2 (en) | 2013-03-15 | 2017-06-13 | Cayman Chemical Company, Inc. | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions |
| CA2903314C (en) | 2013-03-15 | 2023-02-14 | Cayman Chemical Company, Inc. | Methods of synthesizing a difluorolactam analog |
| PT2989098T (pt) * | 2013-03-15 | 2017-08-16 | Cayman Chemical Co Inc | Compostos de lactama como agonistas selectivos do receptor ep4 para uso no tratamento de doenças e condições mediadas por ep4 |
| KR20160048054A (ko) | 2013-07-19 | 2016-05-03 | 카이맨 케미칼 컴파니 인코포레이티드 | 골 성장의 촉진을 위한 방법, 시스템 및 조성물 |
-
1976
- 1976-05-04 DE DE19762619638 patent/DE2619638A1/de active Pending
-
1977
- 1977-04-28 ES ES458264A patent/ES458264A1/es not_active Expired
- 1977-04-29 NL NL7704739A patent/NL7704739A/xx not_active Application Discontinuation
- 1977-05-02 IT IT23096/77A patent/IT1086223B/it active
- 1977-05-03 DK DK194377A patent/DK194377A/da unknown
- 1977-05-03 GB GB18427/77A patent/GB1583163A/en not_active Expired
- 1977-05-04 FR FR7713518A patent/FR2372806A1/fr active Granted
- 1977-05-04 BE BE177278A patent/BE854268A/xx unknown
- 1977-05-04 JP JP5194577A patent/JPS52133975A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2372806B1 (da) | 1980-02-29 |
| NL7704739A (nl) | 1977-11-08 |
| BE854268A (fr) | 1977-11-04 |
| FR2372806A1 (fr) | 1978-06-30 |
| ES458264A1 (es) | 1978-07-16 |
| DE2619638A1 (de) | 1977-11-17 |
| GB1583163A (en) | 1981-01-21 |
| JPS52133975A (en) | 1977-11-09 |
| IT1086223B (it) | 1985-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK120077A (da) | Cycliske sulfonyloxiimider samt deres fremstilling og anvendelse | |
| DK194377A (da) | Pyrrolidoner samt deres fremstilling og anvendelse | |
| DK56876A (da) | Prostaglandinanaloge samt deres fremstilling og anvendelse | |
| DK248177A (da) | Guanidinderivater samt deres fremstilling og anvendelse | |
| DK287476A (da) | Pyrrolidoner samt deres fremstilling og anvendelse | |
| DK358678A (da) | 1,4-bis-amino-anthraquinonforbindelser samt deres anvendelse og fremstilling | |
| DK407577A (da) | Azabicycloforbindelser samt deres fremstilling og anvendelse | |
| DK154877A (da) | Trans-hexahydro-pyrido-indoler samt deres fremstilling og anvendelse | |
| DK97179A (da) | Bicyclooctanderivater samt deres fremstilling og anvendelse | |
| DK474678A (da) | Halogenvinyl-gamma-butyrolactoner samt deres fremstilling og anvendelse | |
| DK83677A (da) | Pyrrolbenzoxazalkaner samt deres fremstilling og anvendelse | |
| DK214577A (da) | Benzensulfonylurinstoffer deres fremstilling og anvendelse | |
| DK513678A (da) | Indolderivater samt deres fremstilling og anvendelse | |
| DK299578A (da) | Bleomyciner samt deres fremstilling og anvendelse | |
| DK581577A (da) | Dehydrooligopeptider samt deres fremstilling og anvendelse | |
| DK227177A (da) | 1-aryloxy-2-hydroxy-3-aminopropaner samt deres fremstilling og anvendelse | |
| DK254077A (da) | Benzylcyanocetaler deres fremstilling og anvendelse | |
| DK554776A (da) | Prostaglandinanaloge pyrrolidoner samt deres fremstilling og anvendelse | |
| DK279777A (da) | Carbostyriler samt deres fremstilling og anvendelse | |
| DK281476A (da) | Pyrrolidoner samt deres fremstilling og anvendelse | |
| DK565277A (da) | Imidazoliner deres fremstilling og anvendelse | |
| DK137778A (da) | Prostansyrederivater samt deres fremstilling og anvendelse | |
| DK574976A (da) | Substituerede cycloalkanpyrazoler samt deres fremstilling og anvendelse | |
| DK84377A (da) | Substituerede phenylguanidiner samt deres fremstilling og anvendelse | |
| DK582378A (da) | Simipermeable membraner samt deres fremstilling og anvendelse |